IONS – ionis pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Ionis to hold first quarter 2026 financial results webcast
Ionis Pharmaceuticals (IONS) was given a new $104.00 price target by Raymond James Financial, Inc..
Ionis Pharmaceuticals (IONS) had its price target raised by Bank of America Corporation from $100.00 to $111.00. They now have a "buy" rating on the stock.
Rare Stock Picks In March 2026 - From 23 Discerning Analysts [Seeking Alpha]
EMA validates indication extension application for Tryngolza® (olezarsen) for the treatment of severe hypertriglyceridemia (sHTG) [Yahoo! Finance]
Form 4 IONIS PHARMACEUTICALS For: Apr 15 Filed by: PARSHALL B LYNNE
Form 4 IONIS PHARMACEUTICALS For: Apr 15 Filed by: Birchler Brian
Form 4 IONIS PHARMACEUTICALS For: Apr 15 Filed by: Baroldi Joseph
Form 4 IONIS PHARMACEUTICALS For: Apr 15 Filed by: Jenne Kyle
Form 144 IONIS PHARMACEUTICALS Filed by: Jenne Kyle
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.